!!! New Study Publication!!!
"Active Chest Tube Clearance Added to an Enhanced Recovery After Cardiac Surgery (ERAS) Program Improves Outcomes and Reduces Resource Utilization"

Adding PleuraFlow’s Active Chest Tube Clearance (ATC) to an ERAS cardiac surgery program reduced Retained Blood Syndrome by 41%, postoperative atrial fibrillation (POAF) by 17%, and ICU time by 30% in 684 patients compared to 650 controls, improving outcomes and resource utilization. (Gerdisch, et al, 2025)

News

NewsArticle

Mark your calendar!

On Friday, OctoPR_iconber 10th investigators will report clinical trial results from the Prevention of Retained Blood Outcomes with Active Clearance Technology (PROACT) assessing the use of PleuraFlow to reduce Retained Blood Complications after Cardiac Surgery at FACTS-Care CVT 2014 in Washington, D.C. This is one of the largest studies to assess outcomes with Active Clearance Technology to reduce complications after heart surgery.